儿科护理中的治疗性血交换:来自第三级护理中心经验的见解
Sphurti Chowdhary1, Krishna Mohan Gulla1, Satya Prakash2
1Department of Pediatrics, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Indian pediatrics
|November 24, 2025
概括
治疗性血交换 (TPE) 对于儿科脏和非脏疾病,包括溶血性尿素性综合征和自身免疫性脑炎是安全有效的. 然而,结果受到延迟呈现和有限的移植选择的影响.
科学领域:
- 儿科脏病学 儿科脏病学
- 儿科神经学 儿科神经学
- 儿科重症监护 儿科重症监护
背景情况:
- 治疗性血交换 (TPE) 是一种用于各种儿科疾病的体外手术.
- 评估TPE在儿童中的安全性,有效性和结果对于优化治疗策略至关重要.
- 高等保健中心在管理复杂的儿科病例中发挥着至关重要的作用,需要像TPE这样的先进疗法.
研究的目的:
- 评估儿科患者治疗性血交换 (TPE) 的安全性,疗效和临床结果.
- 确定从TPE中受益最多的患者子组和影响结果的因素.
- 分析TPE在第三级护理环境中的适应症范围.
主要方法:
- 在2020年1月至2024年7月期间接受TPE的儿科患者的回顾性分析.
- 在印度东部的一家三级医院从医院记录中收集数据.
- 对适应症,TPE周期,患者人口统计和结果的分析.
主要成果:
- 40名儿童接受了184次TPE循环;常见的适应症包括肝病 (35%),病 (27.5%),二次血细胞淋巴细胞结核病 (22.5%).
- 在自身免疫性脑炎和ASFA类别I脏疾病中观察到出色的结果.
- 高死亡率与延迟呈现,器官衰竭和缺乏肝移植设施有关.
结论:
- 治疗性血交换 (TPE) 在治疗儿科血清性尿素综合征和抗N-甲基-D-酸盐受体脑炎方面表现出有效性.
- 在儿童中,TPE可以安全有效地用于和非的指示.
- 优化TPE协议和及时干预对于改善儿科患者的治疗结果至关重要.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Excretion
188
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
188
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
154
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
154
Pharmacokinetics in Pediatric Patients: Drug Distribution
231
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
231
Continuous Renal Replacement Therapy
713
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
713
Acute Kidney Injury V: Interprofessional Care
264
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
264
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
171
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
171


